StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) stock

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$1.06+0.00 (0.00%)

Close on Nov 18, 2026Market cap $116.17KP/E –Yield –

XORTX Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for XORTX Therapeutics

XORTX Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More XORTX Therapeutics figures

See a number that looks wrong?